Hey Steve....please be assured that our expectations are in lock-step with each other. No one I know is really legitimately “upset”, certainly not with you, or others expressing their simple and legitimate human frustrations and I see no legitimate debate.
“The U.S. Market with two approved products, should be our main focus. The Market doesn't want to hear about where we've been, they want to hear about where we going, that being the Grand Prize U.S. Market.”
Let me say this, to perhaps help. The main focus of the company is indeed the U.S. market for the two products already FDA OTC cleared. I have been asked for my opinions, by others, on numerous occasions and by virtue of confidentiality requirements and the protection of corporate strategies, I am restricted from saying more. I gave a commitment to that and will honor it knowing the company has several business positions to protect on several fronts.
You will eventually be amazed at the current timing of things, so please accept what I say. Any reader not doing so does so at their own prerogative.
News 
Market Data 
Discover 
